Alain Joseph

985 total citations
27 papers, 597 citations indexed

About

Alain Joseph is a scholar working on Psychiatry and Mental health, Gastroenterology and Surgery. According to data from OpenAlex, Alain Joseph has authored 27 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Gastroenterology and 7 papers in Surgery. Recurrent topics in Alain Joseph's work include Attention Deficit Hyperactivity Disorder (13 papers), Gastroesophageal reflux and treatments (8 papers) and Gastrointestinal motility and disorders (8 papers). Alain Joseph is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Gastroesophageal reflux and treatments (8 papers) and Gastrointestinal motility and disorders (8 papers). Alain Joseph collaborates with scholars based in United States, United Kingdom and Belgium. Alain Joseph's co-authors include Orly Manor, David L. DuBois, Ruth S. Shalev, Varda Gross‐Tsur, René Kerstens, Jaap van der Meere, Jan Tack, Lieve Vandeplassche, Paul Just and Dale Rublee and has published in prestigious journals such as The Journal of Pediatrics, Journal of Affective Disorders and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Alain Joseph

26 papers receiving 577 citations

Peers

Alain Joseph
Jun Tayama Japan
Alessio Degl’Innocenti Sweden
Minou Mayer United States
Massimo De Carne Italy
Rebecca Firth United States
O. Berndt Scholz Germany
Christine Rigby United Kingdom
Norman Poole United Kingdom
Lynne Hamm United States
Ajit Kumar India
Jun Tayama Japan
Alain Joseph
Citations per year, relative to Alain Joseph Alain Joseph (= 1×) peers Jun Tayama

Countries citing papers authored by Alain Joseph

Since Specialization
Citations

This map shows the geographic impact of Alain Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Joseph more than expected).

Fields of papers citing papers by Alain Joseph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Joseph. The network helps show where Alain Joseph may publish in the future.

Co-authorship network of co-authors of Alain Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Joseph. A scholar is included among the top collaborators of Alain Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Joseph. Alain Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaffe, Dena H., Natalie Flaks‐Manov, Arriel Benis, et al.. (2019). Population-based cohort of 500 patients with Gaucher disease in Israel. BMJ Open. 9(1). e024251–e024251. 12 indexed citations
2.
3.
Joseph, Alain, Rajeev Ayyagari, Meng Xie, et al.. (2017). Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison. European Child & Adolescent Psychiatry. 26(8). 875–897. 25 indexed citations
4.
Coghill, David, Alain Joseph, Vanja Sikirica, et al.. (2017). Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD. Journal of Attention Disorders. 23(13). 1578–1591. 18 indexed citations
5.
Zimovetz, Evelina A., Alain Joseph, Rajeev Ayyagari, & Josephine Mauskopf. (2017). A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK. The European Journal of Health Economics. 19(1). 21–35. 8 indexed citations
6.
Fuller, Garth, Roger Bolus, Cynthia B. Whitman, et al.. (2017). PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease. Digestive Diseases and Sciences. 62(3). 593–606. 7 indexed citations
7.
Thompson, Trevor, Andrew Lloyd, Alain Joseph, & Margaret D. Weiss. (2017). The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis. Quality of Life Research. 26(7). 1879–1885. 42 indexed citations
8.
Asherson, Philip, et al.. (2017). Health-related quality of life and work productivity of adults with ADHD: A UK web-based survey. European Psychiatry. 41(S1). S352–S352. 2 indexed citations
9.
Linhart, Aleš, et al.. (2017). Prompt agalsidase alfa therapy initiation after symptom onset is associated with improved renal and cardiovascular outcomes in the Fabry Outcome Survey. Molecular Genetics and Metabolism. 120(1-2). S85–S85. 1 indexed citations
10.
Joseph, Alain, Martin Cloutier, Annie Guérin, Roy Nitulescu, & Vanja Sikirica. (2016). Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine. Patient Preference and Adherence. 10. 391–391. 3 indexed citations
11.
Joseph, Alain, Keith L. Davis, Moshe Fridman, et al.. (2016). Characteristics and treatment patterns of children and adolescents with attention-deficit/hyperactivity disorder in real-world practice settings. European Psychiatry. 33(S1). s227–s227. 3 indexed citations
12.
Nuijten, Mark, Dominique Dubois, Alain Joseph, & Lieven Annemans. (2015). Cost-effectiveness of prucalopride in the treatment of chronic constipation in the Netherlands. Frontiers in Pharmacology. 6. 67–67. 8 indexed citations
13.
Zimovetz, Evelina A., Matthias Bischof, Alain Joseph, & Josephine Mauskopf. (2015). Cost–utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom. European Psychiatry. 30. 1607–1607. 1 indexed citations
14.
15.
Hodgkins, Paul, et al.. (2014). Economic burden associated with chronic constipation in Sweden: a retrospective cohort study. ClinicoEconomics and Outcomes Research. 6. 369–369. 20 indexed citations
16.
Dik, Vincent K., Peter D. Siersema, Alain Joseph, et al.. (2014). Constipation-related direct medical costs in 16 887 patients newly diagnosed with chronic constipation. European Journal of Gastroenterology & Hepatology. 26(11). 1260–1266. 19 indexed citations
17.
Arfken, Cynthia L., et al.. (2013). The status of sleep abnormalities as a diagnostic test for major depressive disorder. Journal of Affective Disorders. 156. 36–45. 40 indexed citations
18.
Rublee, Dale, et al.. (2000). Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy. 54(3). 209–227. 46 indexed citations
19.
Manor, Orly, et al.. (1997). Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? (vol 130, pg 40, 1997). The Journal of Pediatrics. 130(4). 670–674. 8 indexed citations
20.
Gross‐Tsur, Varda, Orly Manor, Jaap van der Meere, Alain Joseph, & Ruth S. Shalev. (1997). Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective?. The Journal of Pediatrics. 130(4). 670–674. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Tayama Breakdown of academic impact, for papers by Alessio Degl’Innocenti Breakdown of academic impact, for papers by Minou Mayer Breakdown of academic impact, for papers by Massimo De Carne Breakdown of academic impact, for papers by Rebecca Firth Breakdown of academic impact, for papers by O. Berndt Scholz Breakdown of academic impact, for papers by Christine Rigby Breakdown of academic impact, for papers by Norman Poole Breakdown of academic impact, for papers by Lynne Hamm Breakdown of academic impact, for papers by Ajit Kumar
Rankless by CCL
2026